Goldilocks Therapeutics, Inc.
Nanoscale drug delivery platform that selectively targets kidney proximal tubular epithelium to treat acute kidney injury
- Sector
- Biotech
- Headquarters
- Bedford, NY
- Founded
- 2018
- Latest Form D
- $1.2M, Apr 2021
- Total capital
- $1.5M
- Federal grants
- $306K
- 1 award · 2021
- Rank in peer group#20 of 20
- Private capital raised
- $1.2M
- 1 Form D · last Apr 2021
- 66 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 3 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Efficacy and pharmacokinetic assessment of renal-targeted therapy in a pig model of cisplatin induced acute kidney injury.$306K
- Private capital raisedForm D · SEC · 1st filing$1.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 20 peers
Line = medianBiotech · Material
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Arthur KlausnerExecutive Officer, DirectorNamed in SEC Form D filings
- Krishna PoluDirectorNamed in SEC Form D filings
- Scott MinickDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 3- PendingNanoparticles And Methods Of Use ThereofUSPTOApplication PCTUS2021051299
- PendingSynthetic Particles Comprising Nucleic Acid MoleculesUSPTOApplication 63144693
- PendingNanoparticles And Methods Of Use ThereofUSPTOApplication 63081682
Related companies, and why
- Arrevus, Inc.Similar federal contract value in Biotech · null in contracts
- TOPAZ BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- ACCURIUS THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- ALLANDER BIOTECHNOLOGIES, INC.Similar federal contract value in Biotech · null in contracts
- WinSanTor, Inc.Similar federal contract value in Biotech · null in contracts
- Kioga Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .